Company Filing History:
3 out of 23 
2 out of 155 
1 out of 160 
Years Active: 2013-2024
Certainly! Here is the article about inventor Frederik Giesel:
Title: The Innovative Work of Frederik Giesel in Oncology Imaging and Treatment
Introduction:
Frederik Giesel is a renowned inventor based in Heidelberg, Germany, known for his groundbreaking work in the field of radiopharmaceuticals and nuclear medicine. With a total of 4 patents to his name, Frederik Giesel has made significant contributions to the diagnosis and treatment of prostate cancer.
Latest Patents:
1. F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer: This patent focuses on the development of radiopharmaceuticals for use as tracers and imaging agents in prostate cancer diagnostics.
2. Treatment of PMSA expressing cancers: This patent details a method for treating PSMA expressing cancers by administering Ac-225-radiopharmaceuticals in specific dosages to patients in need.
Career Highlights:
Frederik Giesel has been associated with esteemed organizations such as the Ruprecht-Karls-Universitaet Heidelberg and the Deutsches Krebsforschungszentrum. Through his work, he has significantly advanced the field of oncology imaging and treatment, particularly in relation to prostate cancer.
Collaborations:
During his career, Frederik Giesel has collaborated with notable coworkers including Uwe Haberkorn and Jens Cardinale. These collaborations have led to the development of innovative solutions in the realm of radiopharmaceuticals and cancer therapy.
Conclusion:
In conclusion, Frederik Giesel stands as a pioneering figure in the field of oncology, with his inventive patents paving the way for improved diagnostics and treatments in prostate cancer. His continued dedication to research and collaboration underscores his commitment to advancing medical innovations for the benefit of patients worldwide.